BALL Score for Relapsed/Refractory CLL
Evaluates prognosis of patients with relapsed/refractory chronic lymphocytic leukemia (R/R-CLL) on targeted therapies.
Advice
- Results may be helpful for treatment and goals of care discussions between clinicians and patients, guiding decisions regarding management steps, including alternative therapeutic strategies and enrollment in clinical trials.
- Authors of the derivation study suggest that intermediate- and high-risk individuals may benefit from participation in clinical trials.